Jul 30, 2014
John R. Yates, Ph.D., Ernest W. Hahn Professor, Chemical Physiology and Molecular and Cellular Neurobiology at The Scripps Research Institute will deliver the plenary keynote address at the 14th Annual meeting (January 19-23, San Diego, California).
Jul 29, 2014
Bringing Industry, Academia and Regulatory Authorities Together to Produce Safe and Efficacious Products for the Clinic and Beyond
Jul 25, 2014
Interview with Richard A. White, Ph.D., Director, Global Strategy, Breast and Colon Products, Genomic Health, Inc.
Jul 24, 2014
Keynote Presentations Delivered by George Church, Anna Collén, Meir Click and More
Jun 16, 2014
Discussions will be focused on the discovery, detection and treatment of genetic diseases with next generation sequencing
May 07, 2014
Managing the New Treatment Paradigm from Phenotype to Genotype
May 06, 2014
Internationally recognized event for pharma and diagnostics executives, translational scientists, clinicians, business experts, regulators, int'l companion Dx leaders, & other parties involved in drug-diagnostics co-development & precision medicine.
Apr 16, 2014
Cambridge Healthtech Institute discusses the Impact of Academic-Industry Alliances with Dr. Teri Melese during this complimentary podcast, recorded April 2014
Apr 04, 2014
Organized by Cambridge Healthtech Institute (CHI) to be held prior to the start of the 14th Annual Structure-Based Drug Design conference.
Apr 02, 2014
Delegates now have the option to choose from 9 moderated breakout discussion groups on immunogenicity facilitated by industry and academic experts.